×
Download 2024 Brochure
Thank You for Your Support!
Join Us Again Next Year – August 18-20, 2025 in Washington, D.C.

Missed Next Generation Dx Summit this year?

Purchase OnDemand

Missed this year's event? Access content across all of this year's programs On-Demand. At your convenience, access archived presentations for On-Demand learning from anywhere, at any time. Purchase On-Demand


Welcome to the 2024 Next Generation Dx Summit

The Must-Attend Conference for Diagnostic Advancements

Cambridge Healthtech Institute is proud to present the 16th Annual Next Generation Dx Summit which will take place at the Capital Hilton in Washington, D.C., on August 19-21, 2024. The Next Generation Dx Summit is the nexus for international thought leaders to discuss diagnostic advancement and technology innovation. This year’s event provides a valuable window on the state-of-the-art forecasting and future trends in point-of-care and decentralized testing, infectious disease, liquid biopsy, multi-cancer early detection, reimbursement, regulation, and companion diagnostics to improve the standard of care in medicine. This must-attend Summit offers incomparable networking and complete coverage of the most timely and important topics for the industry.

EVENT FEATURES

Benefits of attending include:

  • Form partnerships with major global players in the evolving areas of diagnostics as well as emerging product innovators
  • Gain a comprehensive, up-to-date view of diagnostics, including the latest point-of-care, rapid, decentralized, and pharmacy-based diagnostic tests
  • Gather important industry announcements
  • Hear late-breaking news on the latest trends in regulation and reimbursement
  • Review innovative products, platforms, and technologies in the exhibit hall and poster session
  • Network with peers in industry, government, clinical, and research institutions

2024 PLENARY KEYNOTES

Courtney H. Lias

Talk Title to be Announced

Courtney H. Lias, PhD
Acting Director, OHT7: Office of in vitro Diagnostic Devices,
United States Food and Drug Administration (FDA)


PLENARY PANEL: Laboratory-Developed Tests:

Proposed Rule, Reclassification Activities, Potential Impact, and Path Forward

B. Melina Cimler

MODERATOR:
B. Melina Cimler, PhD, CEO & Founder, PandiaDx LLC

Stefan Burde, PhD

PANELISTS:
Stefan Burde, PhD, Director, Global Strategic Business Development, TÜV SÜD America, Inc.

Girish Putcha

Girish Putcha, MD, PhD, Principal & Founder, Precision Medicine & Diagnostics

Lakshman Ramamurthy, PhD

Lakshman Ramamurthy, PhD, Vice President Regulatory Affairs, GRAIL

Laurie Anna Scrimenti

Anna Scrimenti, Associate Director, Public Policy & Advocacy, Association for Molecular Pathology

800+ Diagnostics PRofessionals
58% of Attendees from IVD & Pharma
60+ Industry Leading Sponsors and Exhibitors
42% C-Suite & Directors

Thank You to Our 2024 Premier Sponsor

AbingdonHealth co-diagnostics

 

View All Sponsors

Engage with Next Generation Dx Summit: Key Contacts

Christina Lingham

For meeting questions or suggestions, please contact:

Christina Lingham
Executive Director,
Conferences and Fellow
Cambridge Healthtech Institute
(+1) 781-972-5464
clingham@healthtech.com

Phillip Zakim-Yacouby

Partnering and Sponsorship
Opportunities

Companies A-K

Phillip Zakim-Yacouby
Senior Business Development Manager
Cambridge Healthtech Institute
781-247-1815
pzakim-yacouby@cambridgeinnovationinstitute.com


Katelin Fitzgerald

Partnering and Sponsorship
Opportunities

Companies L-Z

Katelin Fitzgerald
Sr. Manager, Business Development
Cambridge Healthtech Institute
781-247-1824
kfitzgerald@cambridgeinnovationinstitute.com

Christine Benners

For media and association partnerships, please contact:

Christine Benners
Senior Marketing Manager
Cambridge Healthtech Institute
(+1) 781-247-1820
cbenners@healthtech.com